SCHEMBL31485520

SCHEMBL31485520

NC(=O)Cc1cc(O)c(Br)cc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR6 P51684 1/20 0.36
▸ HKDC1 Q2TB90 1/20 0.36
▸ PTPN1 P18031 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ RAD52 P43351 2/20 0.34
▸ RECQL P46063 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ TDP1 Q9NUW8 2/20 0.34
▸ GAPDH P04406 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ APEX1 P27695 1/20 0.34
▸ BLM P54132 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ CA2 P00918 2/20 0.33
▸ ICMT O60725 1/20 0.33
▸ DGAT1 O75907 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24575335 0.85 KDM1A (0.38) ICMTDGAT1RORC
SCHEMBL29431223 0.84 AKR1B1 (0.42) CCR6HKDC1PTPN1MEN1RAD52
SCHEMBL22775478 0.84 AKR1B1 (0.42) CCR6HKDC1PTPN1MEN1RAD52
SCHEMBL4314806 0.81 KIF11 (0.36) CA2ICMTDGAT1RORCCA12
SCHEMBL16005219 0.79 DGAT1 (0.36) CA2ICMTDGAT1RORCCA12
SCHEMBL31463372 0.78 CCR6 (0.46) CCR6HKDC1MEN1RECQLKMT2A
SCHEMBL29819673 0.77 HDAC1 (0.40) CA2ICMTRORC
SCHEMBL12984764 0.77 HDAC1 (0.40) CA2ICMTRORC
SCHEMBL31551664 0.73 DGAT1 (0.55) MEN1KMT2ADGAT1HSD17B10
SCHEMBL12473692 0.73 DGAT1 (0.50) MEN1KMT2AGAAICMTDGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114616226-B Pyridine derivatives as TMEM16A modulators for the treatment of respiratory disorders TMEM16A有限公司 2025-03-04 — — CN disclosed
Send feedback